• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管成形术期间受累冠状动脉内止血激活的标志物。

Markers of hemostatic activation in affected coronary arteries during angioplasty.

作者信息

Shammas N W, Cunningham M J, Pomerantz R M, Francis C W

机构信息

Cardiology Unit, University of Rochester School of Medicine and Dentistry, New York 14642.

出版信息

Thromb Haemost. 1994 Nov;72(5):672-5.

PMID:7900072
Abstract

To characterize the extent of early activation of the hemostatic system following angioplasty, we obtained blood samples from the involved coronary artery of 11 stable angina patients during the procedure and measured sensitive markers of thrombin formation (fibrinopeptide A, prothrombin fragment 1.2, and soluble fibrin) and of platelet activation (beta-thromboglobulin). Levels of hemostatic markers in venous blood obtained from 14 young individuals with low pretest probability for coronary artery disease were not significantly different from levels in venous blood or intracoronary samples obtained prior to angioplasty. Also, there was no translesional (proximal and distal to the lesion) gradient in any of the hemostatic markers before or after angioplasty in samples obtained between 18 and 21 min from the onset of the first balloon inflation. Furthermore, no significant difference was noted between angioplasty and postangioplasty intracoronary concentrations. We conclude that intracoronary hemostatic activation does not occur in the majority of patients during and immediately following coronary angioplasty when high doses of heparin and aspirin are administered.

摘要

为了描述血管成形术后止血系统早期激活的程度,我们在手术过程中从11例稳定型心绞痛患者的受累冠状动脉采集了血样,并测量了凝血酶形成的敏感标志物(纤维蛋白肽A、凝血酶原片段1.2和可溶性纤维蛋白)以及血小板激活的敏感标志物(β-血小板球蛋白)。从14名冠状动脉疾病预测试概率较低的年轻个体采集的静脉血中的止血标志物水平,与血管成形术前采集的静脉血或冠状动脉内样本中的水平无显著差异。此外,在首次球囊扩张开始后18至21分钟采集的样本中,血管成形术前或术后,任何止血标志物在病变处(病变近端和远端)均无梯度变化。此外,血管成形术期间和术后冠状动脉内浓度之间无显著差异。我们得出结论,当给予高剂量肝素和阿司匹林时,大多数患者在冠状动脉血管成形术期间及术后即刻不会发生冠状动脉内止血激活。

相似文献

1
Markers of hemostatic activation in affected coronary arteries during angioplasty.血管成形术期间受累冠状动脉内止血激活的标志物。
Thromb Haemost. 1994 Nov;72(5):672-5.
2
[Markers of hemostatic activation in the coronary sinus versus peripheral circulation in coronary artery disease. Effects of percutaneous transluminal coronary angioplasty].[冠心病患者冠状窦与外周循环中止血激活标志物。经皮腔内冠状动脉成形术的影响]
Med Clin (Barc). 1998 Nov 7;111(15):578-9.
3
Involvement of tissue factor pathway inhibitor in the coronary circulation of patients with acute coronary syndromes.组织因子途径抑制物在急性冠脉综合征患者冠脉循环中的作用
Circulation. 2003 Dec 9;108(23):2864-9. doi: 10.1161/01.CIR.0000105900.21445.3D. Epub 2003 Dec 1.
4
Systemic and translesional activation of coagulation, fibrinolytic, and inhibitory systems in candidates for coronary angioplasty: basal state and effect of successful dilation.冠状动脉成形术候选者体内凝血、纤溶和抑制系统的全身及病变部位激活:基础状态及成功扩张的影响
Am Heart J. 1999 Feb;137(2):274-83. doi: 10.1053/hj.1999.v137.91540.
5
Activation of coagulation and deep vein thrombosis after bone marrow harvesting and insertion of a Hickman-catheter in ABMT patients with malignant lymphoma.恶性淋巴瘤自体骨髓移植患者进行骨髓采集及插入Hickman导管后凝血激活与深静脉血栓形成
Bone Marrow Transplant. 1996 Apr;17(4):577-81.
6
Characterization of prothrombin activation during cardiac surgery by hemostatic molecular markers.通过止血分子标志物对心脏手术期间凝血酶原激活的特征分析。
Anesthesiology. 1994 Mar;80(3):520-6. doi: 10.1097/00000542-199403000-00007.
7
Antithrombotic treatment (argatroban vs. heparin) in coronary angioplasty in angina pectoris: effects on inflammatory, hemostatic, and endothelium-derived parameters.抗血栓治疗(阿加曲班与肝素对比)用于心绞痛患者冠状动脉血管成形术:对炎症、止血及内皮衍生参数的影响
Thromb Res. 2000 May 15;98(4):269-79. doi: 10.1016/s0049-3848(99)00237-6.
8
Myocardial damage, coagulation activity and the response to thrombin inhibition in unstable coronary artery disease.不稳定型冠状动脉疾病中的心肌损伤、凝血活性及对凝血酶抑制的反应
Thromb Haemost. 2004 Feb;91(2):381-7. doi: 10.1160/TH03-07-0427.
9
The impact of cardiac ischemia and reperfusion on markers of activated haemostasis and fibrinolysis during cardiopulmonary bypass: comparison of plasma levels in arterial and coronary venous blood.体外循环期间心脏缺血再灌注对活化止血和纤维蛋白溶解标志物的影响:动脉血与冠状静脉血中血浆水平的比较
Thromb Res. 2005;116(1):33-9. doi: 10.1016/j.thromres.2004.10.006.
10
Chemotherapy-induced activation of hemostasis: effect of a low molecular weight heparin (dalteparin sodium) on plasma markers of hemostatic activation.化疗诱导的止血激活:低分子量肝素(达肝素钠)对止血激活血浆标志物的影响。
Thromb Haemost. 2002 Aug;88(2):213-20.

引用本文的文献

1
Early changes in local hemostasis activation following percutaneous coronary intervention in stable angina patients: a comparison between drug-eluting and bare metal stents.稳定型心绞痛患者经皮冠状动脉介入治疗后局部止血激活的早期变化:药物洗脱支架与裸金属支架的比较
J Thromb Thrombolysis. 2009 Oct;28(3):333-41. doi: 10.1007/s11239-008-0266-2. Epub 2008 Sep 3.
2
Differential transcriptional regulation of the human thrombin receptor gene by the Sp family of transcription factors in human endothelial cells.人内皮细胞中转录因子Sp家族对人凝血酶受体基因的差异转录调控。
Biochem J. 1998 Mar 15;330 ( Pt 3)(Pt 3):1469-74. doi: 10.1042/bj3301469.